Medical Innovation Exchange

After chat with FDA, ImmunoGen delays pivotal top-line data on blood cancer ADC to 2024

https://www.fiercebiotech.com/biotech/after-chat-fda-immunogen-delays-pivotal-top-line-data-blood-cancer-adc-2024

Leave a Comment

Your email address will not be published.

Leave the field below empty!